BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 7414516)

  • 1. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
    Gapinski PV; Donegan WL
    Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor status as a prognostic indicator for stage I breast cancer patients.
    Crowe JP; Hubay CA; Pearson OH; Marshall JS; Rosenblatt J; Mansour EG; Hermann RE; Jones JC; Flynn WJ; McGuire WL
    Breast Cancer Res Treat; 1982; 2(2):171-6. PubMed ID: 7171837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prediction of hormonal dependency of mammary cancer.
    Block GE; Jensen EV; Polley TZ
    Ann Surg; 1975 Sep; 182(3):342-52. PubMed ID: 169754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptors in primary breast cancer.
    Neifeld JP; Lawrence W; Brown PW; Banks WL; Terz JJ
    Arch Surg; 1982 Jun; 117(6):753-7. PubMed ID: 7082164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid-hormone receptors in breast cancer.
    Wittliff JL
    Cancer; 1984 Feb; 53(3 Suppl):630-43. PubMed ID: 6692266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between estrogen receptor status, axillary-node metastases and disease-free interval after surgery in primary breast cancer.
    Caldarola L; Calderini P; Volterrani P; Di Carlo F; Gaglia P
    Ital J Surg Sci; 1983; 13(3):179-85. PubMed ID: 6643007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on estrogen and progesterone receptors in human breast cancer by sucrose gradient centrifugation (author's transl)].
    Iino Y
    Nihon Naibunpi Gakkai Zasshi; 1979 Aug; 55(8):971-93. PubMed ID: 488478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone receptors: clinical significance and problems in the treatment of breast cancer].
    Izuo M; Iino Y
    Gan No Rinsho; 1983 May; 29(6):637-43. PubMed ID: 6876433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles and indications of endocrine treatment of advanced breast cancer.
    Mouridsen HT; Palshof T
    Recent Results Cancer Res; 1980; 71():112-7. PubMed ID: 7367722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of steroïd hormone receptors in the treatment of human breast cancer: a review.
    Osborne CK; McGuire WL
    Bull Cancer; 1979; 66(3):203-9. PubMed ID: 385079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer.
    Kiang DT; Frenning DH; Goldman AI; Ascensao VF; Kennedy BJ
    N Engl J Med; 1978 Dec; 299(24):1330-4. PubMed ID: 714108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast.
    Paone JF; Abeloff MD; Ettinger DS; Arnold EA; Baker RR
    Surg Gynecol Obstet; 1981 Jan; 152(1):70-4. PubMed ID: 7455895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics.
    Carreño G; Del Casar JM; Corte MD; González LO; Bongera M; Merino AM; Juan G; Obregón R; Martínez E; Vizoso FJ
    Breast Cancer Res Treat; 2007 Mar; 102(1):61-73. PubMed ID: 16850244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor: a prognostic factor in breast cancer.
    Samaan NA; Buzdar AU; Aldinger KA; Schultz PN; Yang KP; Romsdahl MM; Martin R
    Cancer; 1981 Feb; 47(3):554-60. PubMed ID: 7226005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Place of hormone receptor determination in the therapeutic strategy of breast cancer].
    Clavel B; Gest J
    Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor determination and long term survival of patients with carcinoma of the breast.
    Crowe JP; Gordon NH; Hubay CA; Shenk RR; Zollinger RM; Brumberg DJ; McGuire WL; Shuck JM
    Surg Gynecol Obstet; 1991 Oct; 173(4):273-8. PubMed ID: 1925896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Node-negative breast cancer treated by modified radical mastectomy without adjuvant therapies: variables associated with disease recurrence and survivorship.
    Huseby RA; Ownby HE; Frederick J; Brooks S; Russo J; Brennan MJ
    J Clin Oncol; 1988 Jan; 6(1):83-8. PubMed ID: 3335894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer.
    Skinner JR; Wanebo HJ; Betsill WL; Wilhelm MC; Drake CR; Macleod RM
    Ann Surg; 1982 Dec; 196(6):636-41. PubMed ID: 7149814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.